Thursday, May 7, 2026

Is Myeolgong Tteokbokki Truly 100% Korean? Controversy Over Ingredients Sparks Debate

Kim Sang-hyun defends Myeolgong Tteokbokki against ingredient criticism, asserting domestic sourcing while addressing political backlash.

“GOOD BOY, LEE” Kim Yo-jong’s Sickening Praise for the South’s Submissive President

The White House welcomes Kim Yo-jong's praise for President Lee's regret over drone tensions, urging peace on the Korean Peninsula.

Tesla’s Stock Plunges 19% in Just Five Days, Overtaken by Broadcom

Tesla's stock has dropped significantly due to declining European sales, leading to a market cap fall to $935.3 billion.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.

Novo Nordisk Slashes GLP-1 Drug Prices by Up to 50%: What This Means for Obesity Treatments in 2027

Novo Nordisk will cut prices of GLP-1 treatments in the U.S. by up to 50% from January 2027, amid rising competition and market pressures.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

Discover the Future of Aesthetic Treatments: How Nanotechnology is Transforming the Beauty Industry

DongKoo Bio&Pharma partners with Supernova Bio and Areum Medics to innovate aesthetic treatments using advanced nanoparticle technology.

How thynC™ is Revolutionizing Hospital Patient Monitoring: A Deep Dive into the Latest Innovations

Seers Technology's thynC™ platform expands rapidly in hospitals, integrating vital sign monitoring with EMR systems for enhanced patient care.

Hyderabad’s New CKD Production Line: How Huons Meditech and Vasu Group are Revolutionizing Endoscope Sterilizers in India

Huons Meditech inaugurated a CKD production line for endoscope disinfectors in India, enhancing local production and market expansion.

Brivaracetam vs. Levetiracetam: Which Epilepsy Drug Offers Better Safety and Efficacy?

Samjin Pharmaceutical launches Bricetam Tablets, improving epilepsy treatment with fewer side effects and better adherence for patients.

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Can AI Speed Up Drug R&D?: PharmGen Science Teams With Polaris AI Pharma Across the Full Development Cycle

PharmGen Science partners with Polaris AI Pharma to enhance drug development using AI technologies and optimize R&D processes.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

South Korean Researchers Crack the Dry-Electrode Bottleneck: 4x Faster Processing, 3x Stronger EV Battery Electrodes

A research team has improved eco-friendly battery manufacturing, reducing production time by 75% and increasing energy storage capacity.

How Ildong Bioscience is Revolutionizing Health Supplements at Vitafoods India 2026

Ildong Bioscience participated in the 2026 Vitafoods India expo, showcasing innovative health products and seeking partnerships in the healthcare sector.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

Top News

- Our Sponsors Ad -

Follow us